Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives for Sustainability in the Pharmaceuticals Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

The 6P Framework for Sustainability and CE Practices in Pharma

Segmentation by Initiatives across the Pharma Value Chain

Growth Drivers

Growth Restraints

Achieving Sustainability across the Pharma Value Chain

Overview: GHG Emission Scopes

Global Policy Driving Sustainability

Global Policy Driving Sustainability (continued)

Regional Policies/Initiatives Driving Sustainability

Regional Policies/Initiatives Driving Sustainability (continued)

Regional Policies/Initiatives Driving Sustainability (continued)

Regional Policies/Initiatives Driving Sustainability (continued)

Policy—Impact Analysis

Policy—Impact Analysis (continued)

Policy—Impact Analysis (continued)

Policy—Impact Analysis (continued)

Trends Advancing Sustainability in the Pharma Value Chain

Trends Advancing Sustainability in the Pharma Value Chain (continued)

Business Models for Achieving Sustainability

Business Models for Achieving Sustainability (continued)

Business Models for Achieving Sustainability (continued)

Top 4 Business Models—Impact Summary

Companies to Action—Alignment to SDGs and the 6P Framework

Companies to Action—Alignment to SDGs and the 6P Framework (continued)

Companies to Action—Alignment to SDGs and the 6P Framework (continued)

Overview—Products for Sustainability

Future Focus Areas—Sustainable Research

Products-in-focus—Eco-friendly Research Solutions

Sustainable Feedstocks—R&D in Marine-derived Pharma Products

Sustainability in Manufacturing—Touchpoints

Overview—Processes for Achieving Sustainability

Future Focus Areas—Sustainable Manufacturing

Processes-in-focus—Technology Implementation for Decarbonization

Future Prospect of Intelligent Tools in the Pathway of Policy to Platform

Partnerships as a Business-to-business Opportunity for Achieving Sustainability

Future Focus Areas—Sustainable Packaging and Distribution

Partnerships-in-focus—Life Cycle Assessment (LCA) for CE

Future Prospect—Technology-enabled Design Innovation

J&J

AZ

Pfizer

PPS

Amcor

Growth Opportunity 1: Sustainable Research, Benign-by-Design

Growth Opportunity 1: Sustainable Research, Benign-by-Design (continued)

Growth Opportunity 2: Carbon Footprint Reduction in Pharma Value Chain

Growth Opportunity 2: Carbon Footprint Reduction in Pharma Value Chain (continued)

Growth Opportunity 3: Platforms for ESG-based Growth Strategy

Growth Opportunity 3: Platforms for ESG-based Growth Strategy (continued)

Growth Opportunity 4: Managing Pharma Waste Sustainably

Growth Opportunity 4: Managing Pharma Waste Sustainably (continued)

List of Exhibits

Legal Disclaimer